The main changes S-280 would make, in plain reading order.
This enactment provides for the development of a national framework to support Canadians with sickle cell disease (also known as sickle cell anemia or drepanocytosis), their families and their caregivers.
Your note
Personal note about S-280
Saved on this device only. Star the bill to see your note on its card.
Committee study
After second reading, a committee examines the bill clause by clause.
Who's lobbying on it
5 organizations named this bill in their lobbying registration or in
0 reported meetings. Their own words are quoted.
Vertex Pharmaceuticals (Canada) Inc.
was registered on it · latest Jun 3, 2025
“Engagement with officials on Bill S-280, An Act respecting a national framework on sickle cell disease, to discuss measures and initiatives to improve care and treatment of Canadians affected by sickle cell…”
Vertex Pharmaceuticals (Canada) Inc.
was registered on it · latest Feb 3, 2025
“Engagement with officials on Bill S-280, An Act respecting a national framework on sickle cell disease, to discuss measures and initiatives to improve care and treatment of Canadians affected by sickle cell…”
Vertex Pharmaceuticals (Canada) Inc.
was registered on it · latest Feb 3, 2025
“Engagement with officials on Bill S-280, An Act respecting a national framework on sickle cell disease, to discuss measures and initiatives to improve care and treatment of Canadians affected by sickle cell…”
Vertex Pharmaceuticals (Canada) Inc.
was registered on it · latest Jul 19, 2024
“Engagement with officials on Bill S-280, An Act respecting a national framework on sickle cell disease, to discuss measures and initiatives to improve care and treatment of Canadians affected by sickle cell…”
Vertex Pharmaceuticals (Canada) Inc.
was registered on it · latest May 8, 2024
“Engagement with officials on Bill S-280, An Act respecting a national framework on sickle cell disease, to discuss measures and initiatives to improve care and treatment of Canadians affected by sickle cell…”
From the Commissioner of Lobbying. A bill is listed when the lobbyist's description makes clear it means this bill, not one with the same number from another Parliament.